Amedeo Smart

Free Medical Literature Service

 

Amedeo

Drug Resistance
  Free Subscription

Articles published in
J Infect Chemother
    August 2026
  1. ETANI T, Kondo S, Morikawa T, Aoki M, et al
    Clinical characteristics of Providencia rettgeri bacteraemia and antimicrobial susceptibility patterns.
    J Infect Chemother. 2026;32:103025.
    >> Share

  2. YANO H, Suzuki K, Kamide Y, Hotomi M, et al
    Nationwide surveillance of antibacterial susceptibility patterns of bacterial pathogens isolated from otorhinolaryngological infectious diseases in Japan.
    J Infect Chemother. 2026;32:102995.
    >> Share

    July 2026
  3. YAMANE T, Denda T, Natori T, Kamijo T, et al
    Occurrence of bla(OXA-72) in a clinical isolate of carbapenem-resistant Acinetobacter pittii ST206 in Japan.
    J Infect Chemother. 2026 Jul 17:103036. doi: 10.1016/j.jiac.2026.103036.
    >> Share

  4. HASHIMOTO T, Goto E, Matsumoto H, Hiramatsu K, et al
    Antimicrobial susceptibility and resistance gene profiles of Prevotella spp. isolated in Oita University Hospital, Japan.
    J Infect Chemother. 2026;32:103001.
    >> Share

    June 2026
  5. OTA Y, Nagahara Y, Watanabe R, Isoda T, et al
    Emergence of Klebsiella variicola harboring bla(KPC-2) and bla(CTX-M-15) on an IncP-6/IncR hybrid plasmid from a bloodstream infection case in Japan.
    J Infect Chemother. 2026;32:102970.
    >> Share

    May 2026
  6. LE YH, Hoang HTT, Khong DT, Nguyen TN, et al
    High prevalence of atypical enteropathogenic Escherichia coli contaminating retail chicken meat in Vietnam: virulence gene profiles, sequence types, and antimicrobial resistance.
    J Infect Chemother. 2026 May 19:102998. doi: 10.1016/j.jiac.2026.102998.
    >> Share

  7. SATO W, Sedohara A, Ichimura H, Koga M, et al
    Molecular Epidemiology of Treponema pallidum subsp. pallidum among Men Who Have Sex with Men at a HIV Referral Hospital in Tokyo: Multilocus Sequence Typing and Macrolide Resistance.
    J Infect Chemother. 2026 May 1:102984. doi: 10.1016/j.jiac.2026.102984.
    >> Share

    April 2026
  8. MAKINO J, Honda M, Sato F, Morikawa Y, et al
    Clinical impact of antimicrobial de-escalation in critically ill patients: A single-center cohort study.
    J Infect Chemother. 2026;32:102946.
    >> Share

  9. ANRAKU M, Nakano S, Yamaguchi T, Nishijima S, et al
    Molecular characterization of O25:H4 ST131 extraintestinal pathogenic Escherichia coli (ExPEC) harboring a bla(OXA-48)-carrying IncFII plasmid.
    J Infect Chemother. 2026;32:102941.
    >> Share

    February 2026
  10. OGAWA S, Fukushima S, Yamamoto M, Tsuji S, et al
    Comments on "In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in Japan".
    J Infect Chemother. 2026;32:102933.
    >> Share

  11. NAKAMURA A, Nakamura T, Niki M, Kuchibiro T, et al
    Comprehensive genomic analysis of ESBL- and carbapenemase-producing Escherichia coli ST131 in Japan: Genetic characteristics of pandemic clade C.
    J Infect Chemother. 2026;32:102915.
    >> Share

  12. OKANDA T, Nakajima N, Koshikawa T, Oyanagi T, et al
    Evaluation of Japan-specific cefiderocol susceptibility testing methods in multidrug-resistant gram-negative isolates from Japan and Bangladesh.
    J Infect Chemother. 2026;32:102903.
    >> Share

    January 2026
  13. TANIGUCHI K, Yamaguchi T, Isoda K, Shiomi M, et al
    Clinical and Microbiological Characteristics of macrolide-resistant Bordetella pertussis Infection: A case series in Osaka, Japan (2024-2025).
    J Infect Chemother. 2026 Jan 27:102916. doi: 10.1016/j.jiac.2026.102916.
    >> Share

  14. KURAMOCHI Y, Shibata M, Morinaga M, Tame T, et al
    Microbiologic clearance in macrolide-resistant Bordetella pertussis: An infant treated with sulfamethoxazole-trimethoprim - A case timeline.
    J Infect Chemother. 2026;32:102907.
    >> Share

  15. MATSUI K, Sakurai A, Matsumura Y, Hosoda T, et al
    In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in Japan.
    J Infect Chemother. 2026 Jan 6:102905. doi: 10.1016/j.jiac.2026.102905.
    >> Share

  16. HIOKI T, Mutoh Y, Umemura T, Ishihara Y, et al
    Xpert MTB/RIF probe reactivity to non-tuberculosis mycobacteria cultured in MGIT broth samples.
    J Infect Chemother. 2026;32:102891.
    >> Share

    December 2025
  17. TURKER N, Korkmaz OE, Aydogmus FK, Ayhan Genis NM, et al
    Carbapenem Resistant Gram Negative Bacteremia in Intensive Care Unit Patients: Development and Validation of a Nomogram-Based 30-Day Mortality Risk Prediction Model.
    J Infect Chemother. 2025 Dec 27:102902. doi: 10.1016/j.jiac.2025.102902.
    >> Share

  18. HIKIDA S, Akiyama Y, Ishikane M, Shimazu H, et al
    Echinocandin-resistant Candida albicans: A case report from Japan.
    J Infect Chemother. 2025;31:102856.
    >> Share

  19. SALEEM M, Syed Khaja AS, Moursi S, Mohammed GEY, et al
    Distribution and antifungal susceptibility of Candida species in pelvic inflammatory disease patients from Hail, Saudi Arabia: A retrospective study.
    J Infect Chemother. 2025;31:102855.
    >> Share

  20. KURI K, Kinoshita-Daitoku R, Arakawa Y, Shibayama K, et al
    Development of two methods for detecting Streptococcus mitis/oralis-related species with meropenem-non-susceptibility.
    J Infect Chemother. 2025;31:102846.
    >> Share

  21. YASUDA M, Takahashi S, Oba S, Kumagai C, et al
    The fourth nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2021.
    J Infect Chemother. 2025;31:102841.
    >> Share

    November 2025
  22. FUKUSHIMA-NOMURA A, Takamiyagi S, Ito Y, Sawada K, et al
    Recurrent familial furunculosis associated with Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus sublineage of the USA300 clone in Tokyo.
    J Infect Chemother. 2025 Nov 19:102872. doi: 10.1016/j.jiac.2025.102872.
    >> Share

  23. RAMS TE, van Winkelhoff AJ
    Susceptibility of multidrug-resistant Aggregatibacter actinomycetemcomitans in vitro to amoxicillin-metronidazole and ciprofloxacin.
    J Infect Chemother. 2025;31:102836.
    >> Share

  24. YAMAZAKI K, Osada M, Maruguchi N, Arai T, et al
    Successful combination therapy with voriconazole and micafungin for voriconazole-resistant Scedosporium dehoogii pulmonary infection: A case report with in vitro analysis.
    J Infect Chemother. 2025;31:102832.
    >> Share

  25. HOSHINO T, Takeuchi N, Okada H, Takahashi K, et al
    Clinical features of pediatric invasive Escherichia coli disease: A study at seven facilities in Chiba prefecture in Japan.
    J Infect Chemother. 2025;31:102825.
    >> Share

    October 2025
  26. JUNG J, Kim YK, Chang E, Bae S, et al
    Corrigendum to 'The origin of sequence type 72 community-associated methicillin-resistant Staphylococcus aureus (MRSA) and fusidic acid (FA) resistant sequence type 5 MRSA: Analysis of FA resistance and spa type in a single center in South Korea'[Jour
    J Infect Chemother. 2025 Oct 30:102847. doi: 10.1016/j.jiac.2025.102847.
    >> Share

  27. ISHIWADA N, Nishi J, Fujimaki K, Takahashi S, et al
    Nationwide surveillance of bacterial pathogens isolated from children by the surveillance committee of the Japanese society of chemotherapy, Japanese association for infectious diseases, and Japanese society for clinical microbiology between April 202
    J Infect Chemother. 2025;31:102812.
    >> Share

  28. TAKAHASHI J, Yajima T, Kawaguchiya M, Hashimoto N, et al
    Nosocomial outbreak of multidrug-resistant Streptococcus pneumoniae serotype 15A (non-vaccine serotype) in a community hospital.
    J Infect Chemother. 2025;31:102811.
    >> Share

  29. TOKIMATSU I, Fujikura Y, Matsumoto T, Tsukada H, et al
    Nationwide surveillance of antibacterial susceptibility in bacterial respiratory pathogens in Japan, 2022-2023.
    J Infect Chemother. 2025;31:102781.
    >> Share

    September 2025
  30. MIYAZAKI N, Kurumiya A, Takayama M, Kawamoto Y, et al
    Efficacy of Hydrogen Peroxide Vaporizing Against Methicillin-Resistant Staphylococcus aureus, Extended-Spectrum beta-Lactamase-Producing Bacteria, and Clostridioides difficile.
    J Infect Chemother. 2025 Sep 26:102820. doi: 10.1016/j.jiac.2025.102820.
    >> Share

  31. SHIGEMOTO N, Mikamo H, Hata H, Sato J, et al
    Fourth nationwide surveillance of the antimicrobial susceptibility patterns of pathogens isolated from surgical site infections in Japan.
    J Infect Chemother. 2025;31:102776.
    >> Share

  32. NAGASE Y, Hayakawa K, Kubo T, Okumura N, et al
    Effectiveness of intramuscular spectinomycin in difficult-to-treat Mycoplasma genitalium urethritis in four cases.
    J Infect Chemother. 2025;31:102775.
    >> Share

  33. HAYAKAWA K, Kiga K, Ojima S, Chihara K, et al
    A feasibility study for personalized phage therapy against drug-resistant bacteria in Japan.
    J Infect Chemother. 2025;31:102770.
    >> Share

    August 2025
  34. SHIBATA Y, Asai N, Hagihara M, Mikamo H, et al
    Clinical characteristics and antibiotic susceptibility of Lactobacillus bacteremia: A retrospective analysis.
    J Infect Chemother. 2025 Aug 15:102794. doi: 10.1016/j.jiac.2025.102794.
    >> Share

  35. MURA T, Aso M, Kawamura K, Kanaya K, et al
    Case report: false-negative Xpert MRSA/SA BC result due to spa gene deletion in a patient with methicillin-resistant Staphylococcus aureus bacteremia.
    J Infect Chemother. 2025 Aug 4:102780. doi: 10.1016/j.jiac.2025.102780.
    >> Share

  36. QUIRINO A, Cicino C, Marascio N, Barreca GS, et al
    Molecular versus conventional assay for diagnosis of hospital-acquired pneumonia in critically ill patients: a single center experience.
    J Infect Chemother. 2025;31:102754.
    >> Share

  37. KRISHNAMOORTHY Y, Govindan D, Karunakaran M, Parveen M, et al
    Global impact of antimicrobial stewardship programs in Healthcare: An umbrella review of effectiveness, cost-efficiency, and implementation strategies.
    J Infect Chemother. 2025;31:102753.
    >> Share

    July 2025
  38. DANZUKA Y, Nakamura K, Matsumoto S, Etoh Y, et al
    Successive SARS-CoV-2 mutations in a highly susceptible host: A case report of persistent viremia and fatality.
    J Infect Chemother. 2025;31:102737.
    >> Share

  39. KANEKO A, Iwabuchi H, Sato J, Matsumoto T, et al
    Antimicrobial susceptibility surveillance of bacterial isolates recovered in Japan from odontogenic infections in 2018.
    J Infect Chemother. 2025;31:102731.
    >> Share

  40. LOTFIAN Z, Nave HH, Khalili R, Saffari F, et al
    Contribution of efflux activity in resistance to antibiotics in Escherichia coli clinical isolates.
    J Infect Chemother. 2025;31:102725.
    >> Share

    June 2025
  41. ISHIKAWA K, Shibutani K, Mikami Y, Harada S, et al
    Successful treatment of an intra-abdominal abscess caused by KPC-2-producing hypervirulent Klebsiella pneumoniae sequence type 11 with imipenem/cilastatin/relebactam in a Japanese patient.
    J Infect Chemother. 2025;31:102717.
    >> Share

  42. SASAKI Y, Horiuchi H, Umehara A, Yano M, et al
    Longitudinal impact of a pharmacist-led stepwise antimicrobial stewardship program on intravenous antimicrobial use at a small resource-limited Japanese hospital.
    J Infect Chemother. 2025;31:102697.
    >> Share

    May 2025
  43. YAMAMOTO K, Hayashi H, Mizuta K, Fukushima R, et al
    Impact of the COVID-19 pandemic on the regional epidemiology of methicillin-resistant Staphylococcus aureus in the Kumamoto region.
    J Infect Chemother. 2025 May 29:102743. doi: 10.1016/j.jiac.2025.102743.
    >> Share

  44. IWASAKI T, Koide K, Kido T, Nakagawa S, et al
    Fatal Case of Macrolide-Resistant Bordetella pertussis Infection, Japan, 2024.
    J Infect Chemother. 2025 May 8:102727. doi: 10.1016/j.jiac.2025.102727.
    >> Share

    April 2025
  45. FURUYA K, Sugiyama K, Suzuki K, Yamamoto M, et al
    Active surveillance of vancomycin-resistant Enterococcus faecium after its outbreak at patient admission.
    J Infect Chemother. 2025;31:102718.
    >> Share

  46. UMEMURA K, Katada Y, Katsube Y, Hira D, et al
    Optimizing cytomegalovirus treatment through therapeutic drug monitoring in a ganciclovir-unresponsive lung transplant recipient.
    J Infect Chemother. 2025;31:102686.
    >> Share

  47. THANH HOANG HT, Yamamoto M, Calvopina M, Bastidas-Caldes C, et al
    Ban of colistin livestock feed supplementation decreased the prevalence of colistin-resistant Escherichia coli in Ecuador.
    J Infect Chemother. 2025;31:102682.
    >> Share

  48. KANESAKA I, Manoharan-Basil SS, De Block T, Kenyon C, et al
    Antimicrobial susceptibility of commensal Neisseria species in the Japanese population.
    J Infect Chemother. 2025;31:102670.
    >> Share

  49. ZHU X, Ye T, Sun Y, Wang S, et al
    Transmission of a plasmid harboring NDM-1 gene between Salmonella Typhimurium and Escherichia coli strains in an infant.
    J Infect Chemother. 2025;31:102655.
    >> Share

  50. SEMERCI Z, Akilli FM, Ilki A
    Evaluation of fosfomycin susceptibility testing methods: A focus on multidrug-resistant Klebsiella pneumoniae using ECOFF values.
    J Infect Chemother. 2025;31:102643.
    >> Share

  51. SHIMADA T, Watanabe A, Akita K, Bando K, et al
    First reported case of disseminated Cunninghamella phaeospora infection with multidrug resistance in acute myeloid leukemia.
    J Infect Chemother. 2025;31:102646.
    >> Share

  52. HASSAN BAR, Mohammed AH
    Development and validation of a knowledge questionnaire regarding the relationship between bacterial resistance and cancer among oncologists.
    J Infect Chemother. 2025;31:102638.
    >> Share

  53. MARUYAMA K, Sekiya K, Yanagida N, Yasuda S, et al
    Seasonal variation in intravenous broad-spectrum antimicrobial use in Japan from 2018 to 2023.
    J Infect Chemother. 2025;31:102636.
    >> Share

  54. MUHAMAD NDA, Kanie N, Otsubo Y, Suzuki K, et al
    Letermovir-inclusive combination therapy for a refractory and resistant infection by cytomegalovirus with UL54 mutation following a hematopoietic stem cell transplant for MHC class II deficiency.
    J Infect Chemother. 2025;31:102627.
    >> Share

    March 2025
  55. TAKAHASHI H, Ohama Y, Horiba K, Fukusumi M, et al
    Emergence of high-level penicillin-resistant Neisseria meningitidis harboring ROB-1-type beta-lactamase gene in Japan.
    J Infect Chemother. 2025 Mar 11:102679. doi: 10.1016/j.jiac.2025.102679.
    >> Share

  56. FERJANI S, Hamzaoui Z, Kanzari L, Fakhfekh A, et al
    Emergence of a methicillin-resistant Staphylococcus aureus strains with an unusual susceptibility antibiotic pattern in Tunisia.
    J Infect Chemother. 2025;31:102677.
    >> Share

    February 2025
  57. FUKUSHIMA S, Hagiya H, Gotoh K, Tsuji S, et al
    Clinical and microbiological characteristics of high-level daptomycin-resistant Corynebacterium species: A systematic scoping review.
    J Infect Chemother. 2025;31:102575.
    >> Share

  58. TSUYAMA N, Okawa N, Muranaka E, Mito H, et al
    Two cases with extensively drug-resistant Salmonella Typhi infection returning from Pakistan.
    J Infect Chemother. 2025;31:102568.
    >> Share

  59. HAMADA Y, Yagi Y
    Therapeutic drug monitoring of azole antifungal agents.
    J Infect Chemother. 2025;31:102535.
    >> Share

    January 2025
  60. LACINEL GURLEVIK S, Oygar PD, Koseoglu B, Hazirolan G, et al
    Is the high dose extended infusion of meropenem useful in the treatment of highly resistant gram-negative bacteria in children?
    J Infect Chemother. 2025;31:102498.
    >> Share

    December 2024
  61. CHLOE CHUI SL, Lai SW, Huang PY, Cherrie Pang CC, et al
    Knowledge, perception, and behaviours related to antibiotic use and antimicrobial resistance in community-dwelling individuals in Hong Kong.
    J Infect Chemother. 2024 Dec 11:S1341-321X(24)00330.
    >> Share

    November 2024
  62. BROOK I
    Overview of anaerobic infections in children and their treatment.
    J Infect Chemother. 2024;30:1104-1113.
    >> Share

    October 2024
  63. KOMEDA T, Hishinuma T, Kirikae T, Tada T, et al
    Escherichia coli with increased aminoglycoside resistance due to an amino acid substitution at position 85 of HemC.
    J Infect Chemother. 2024 Oct 5:S1341-321X(24)00277.
    >> Share

  64. HEMEDA MS, Elsayed HA, Mohamad AME, Ibrahim MM, et al
    Investigation of metronidazole resistance-associated mutations and virulence genotypes in helicobacter pylori isolates from the Egyptian population: A cross-sectional study.
    J Infect Chemother. 2024 Oct 2:S1341-321X(24)00274.
    >> Share

  65. MORIOKA S, Tsuzuki S, Gu Y, Fujitomo Y, et al
    Factors associated with the change of antimicrobial prescription before and after the national action plan on antimicrobial resistance: Additional analysis of a nationwide survey conducted by the Japanese Society of Chemotherapy and the Japanese Assoc
    J Infect Chemother. 2024 Oct 2:S1341-321X(24)00273.
    >> Share

  66. YOO IY, Ha SI, Kim SW, Kim JK, et al
    Carbapenem non-susceptibility overcalling by BD phoenix NMIC-500 panel.
    J Infect Chemother. 2024;30:1076-1080.
    >> Share

  67. ALMANGOUR TA, Ghonem L, Alassiri D, Aljurbua A, et al
    Novel beta-lactam-beta-lactamase inhibitors as monotherapy versus combination for the treatment of drug-resistant Pseudomonas aeruginosa infections: A multicenter cohort study.
    J Infect Chemother. 2024;30:1008-1014.
    >> Share

  68. LEE M, Lee CM, Byun JM, Shin DY, et al
    Risk factors for resistant gram-positive bacteremia in febrile neutropenic patients with cancer.
    J Infect Chemother. 2024;30:995-1000.
    >> Share

    September 2024
  69. NAJARI E, Zamani S, Sheikh Arabi M, Ardebili A, et al
    Antimicrobial photodynamic effect of the photosensitizer riboflavin, alone and in combination with colistin, against pandrug-resistant Pseudomonas aeruginosa clinical isolates.
    J Infect Chemother. 2024;30:892-898.
    >> Share

  70. HARADA K, Miyamoto T, Sugiyama M, Asai T, et al
    First report of a bla(NDM-5)-carrying Escherichia coli sequence type 12 isolated from a dog with pyometra in Japan.
    J Infect Chemother. 2024;30:938-941.
    >> Share

    August 2024
  71. MATSUMOTO M, Hamasuna R, Wada K, Sadahira T, et al
    Fluoroquinolone resistance and clinical characteristics of acute bacterial prostatitis in Japan: A multicenter study by the Japanese research group for urinary tract infection.
    J Infect Chemother. 2024 Aug 14:S1341-321X(24)00221.
    >> Share

  72. UKAI T, Ohkado A, Okumura M, Yoshiyama T, et al
    Two Cases of Iatrogenic Levofloxacin-Resistant Pre-XDR Tuberculosis in Japan.
    J Infect Chemother. 2024 Aug 6:S1341-321X(24)00212.
    >> Share

  73. ITO A, Nanjo Y, Kajiwara C, Shiozawa A, et al
    Intrinsic clarithromycin heteroresistance in Mycobacterium avium.
    J Infect Chemother. 2024;30:752-756.
    >> Share

    July 2024
  74. MITSUMOTO-KASEIDA F, Murata M, Ota K, Kaku N, et al
    Comparison of the effectiveness of core genome multilocus sequence typing and polymerase chain reaction-based open reading frame typing in tracing nosocomial methicillin-resistant Staphylococcus aureus transmission.
    J Infect Chemother. 2024 Jul 4:S1341-321X(24)00179.
    >> Share

    June 2024
  75. ALHARTHI KF, Baotob SM, Bankhar AM, Alsehli AA, et al
    Characteristics and outcomes of urinary tract infections caused by Enterococci: A multicenter retrospective study from two tertiary hospitals in Saudi Arabia.
    J Infect Chemother. 2024 Jun 26:S1341-321X(24)00174.
    >> Share

  76. MITSUTAKE K, Shinya N, Seki M, Ohara T, et al
    Clinical characteristics and analysis of prognostic factors in methicillin-resistant Staphylococcus aureus endocarditis: A retrospective multicenter study in Japan.
    J Infect Chemother. 2024 Jun 12:S1341-321X(24)00157.
    >> Share

  77. SAXENA S, Aggarwal P, Mitra S, Singh S, et al
    In Vitro Assessment of Newer Colistin-Sparing Antimicrobial Agents for Clinical Isolates of Carbapenem-Resistant Organisms.
    J Infect Chemother. 2024 Jun 3:S1341-321X(24)00149.
    >> Share

  78. SHARMA M, Dwivedi P, Joshi V, Singh P, et al
    Novel mutations found in Mycobacterium leprae DNA repair gene nth from central India.
    J Infect Chemother. 2024;30:531-535.
    >> Share

    May 2024
  79. MASAYUKI M, Sunaga T, Sato MT, Hasegawa T, et al
    Efficacy of carbapenems and alternative antimicrobials for treating complicated urinary tract infections caused by caused by third-generation cephalosporin-resistant gram-negative bacteria: A systematic review and meta-analysis of randomised controlle
    J Infect Chemother. 2024 May 3:S1341-321X(24)00127.
    >> Share

    April 2024
  80. KOBAYASHI K, Takahashi S, Yasuda M, Miyazaki J, et al
    Fourth national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from patients with complicated urinary tract infections.
    J Infect Chemother. 2024 Apr 6:S1341-321X(24)00108.
    >> Share

  81. MIURA-AJIMA N, Suwanthada P, Kongsoi S, Kim H, et al
    Effect of WQ-3334 on Campylobacter jejuni carrying a DNA gyrase with dominant amino acid substitutions conferring quinolone resistance.
    J Infect Chemother. 2024 Apr 3:S1341-321X(24)00110.
    >> Share

    March 2024
  82. OGIHARA S, Yamaguchi T, Sato T, Aoki K, et al
    Assessing the discriminability of PCR-based open reading frame typing versus single-nucleotide polymorphism analysis via draft whole-genome sequencing of methicillin-resistant Staphylococcus aureus in nosocomial transmission analysis.
    J Infect Chemother. 2024 Mar 2:S1341-321X(24)00056.
    >> Share

  83. LI Q, Tian P, Xu C, Peng Z, et al
    Increased expression of Mycobacterium tuberculosis Rv3737 gene associated with low-level amikacin resistance.
    J Infect Chemother. 2024;30:208-212.
    >> Share

  84. MITSUTAKE K, Shinya N, Seki M, Ohara T, et al
    Antimicrobial therapy and outcome of methicillin-resistant Staphylococcus aureus endocarditis: A retrospective multicenter study in Japan.
    J Infect Chemother. 2024 Mar 1:S1341-321X(24)00068.
    >> Share

    January 2024
  85. VIECELI T, Henrique LR, Rech TH, Zavascki AP, et al
    Colistin versus polymyxin B for the treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
    J Infect Chemother. 2024 Jan 18:S1341-321X(24)00022.
    >> Share

  86. ZHEN S, Lin Q, Chen Z, Shen Y, et al
    Ceftazidime-avibactam in the treatment of bacteremia due to carbapenem-resistant gram-negative bacteria in hematological patients: Experience in a single center.
    J Infect Chemother. 2024 Jan 10:S1341-321X(24)00011.
    >> Share

  87. YOKOTA K, Kawakami K
    Efficacy and side-effect profile of tedizolid in the treatment of streptococcal toxic shock syndrome due to clindamycin-resistant Streptococcus pyogenes: A case report.
    J Infect Chemother. 2024 Jan 6:S1341-321X(24)00004.
    >> Share

    December 2023
  88. EDA H, Arakawa Y, Yoshida T, Ogasawara F, et al
    Unilateral lymphadenitis caused by community-associated methicillin-resistant Staphylococcus aureus ST834 strain.
    J Infect Chemother. 2023 Dec 12:S1341-321X(23)00309.
    >> Share

  89. KOSAI K, Yamagishi Y, Mikamo H, Ishii Y, et al
    Epidemiological analysis and antimicrobial susceptibility profile of Gram-negative bacilli that cause bacteremia in Japan.
    J Infect Chemother. 2023;29:1091-1096.
    >> Share

    November 2023
  90. OMORI K, Kitagawa H, Takada M, Maeda R, et al
    Fosfomycin as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia: A case series and review of the literature.
    J Infect Chemother. 2023 Nov 3:S1341-321X(23)00269.
    >> Share

    October 2023
  91. JUNG J, Kim YK, Chang E, Bae S, et al
    The origin of sequence type 72 community-associated methicillin-resistant Staphylococcus aureus (MRSA) and fusidic acid (FA) resistant sequence type 5 MRSA: Analysis of FA resistance and spa type in a single center in South Korea.
    J Infect Chemother. 2023 Oct 27:S1341-321X(23)00265.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016